
<http://bio2rdf.org/drugbank:DB00043> a <http://schema.org/Drug> ;
	<http://schema.org/name> "Omalizumab" ;
	<http://schema.org/description> "A recombinant DNA-derived humanized IgG1k monoclonal antibody that selectively binds to human immunoglobulin E (IgE). Xolair is produced by a Chinese hamster ovary cell suspension culture in a nutrient medium containing the antibiotic gentamicin." ;
	<http://schema.org/url> "https://www.drugbank.ca/drugs/DB00043" ;
	<http://schema.org/doseSchedule> "202.5 mg/1.4mL Injection, solution form with subcutaneous route" ;
	<http://schema.org/legalStatus> "investigational" ;
	<http://schema.org/mechanismOfAction> "Xolair binds to IgE (a class of antibodies normally secreted in allergic responses), which prevents their binding to mast cells and basophils." ;
	<http://schema.org/alternateName> "Ig gamma-1 chain C region" ;
	<http://schema.org/sameAs> "https://www.drugbank.ca/drugs/DB00043" .
